Cirdan Ltd, a leader in innovative software and imaging solutions for the diagnosis enhancement sector, has successfully raised £7,500,000 in its latest funding round. Founded in 2010 and headquartered in Lisburn, Northern Ireland, with additional offices in Canada and Australia, Cirdan has carved a niche in optimizing pathology and clinical laboratory usage. The company’s flagship product, ULTRA, is a world-class Laboratory Information System that streamlines laboratory operations and has earned its place in over 72 labs spread across six continents, underscoring its global impact. Additionally, Cirdan’s PathLite Compact offers a specialized solution for gross imaging within clinical laboratories, further expanding its suite of innovative tools.
The newly acquired funds will be pivotal in driving the next phase of Cirdan’s growth, enabling the company to accelerate research and development efforts aimed at enhancing its existing product portfolio while also exploring new technologies. The funding will also bolster Cirdan’s commitment to advancing the field of pathology through initiatives like the Pathology Horizons conference, which serves as a vital platform for ongoing professional development in the discipline. With this financial boost, Cirdan is poised to continue its mission of improving diagnostic accuracy, ultimately benefiting healthcare providers and patients worldwide. For more information on their innovations and initiatives, visit www.pathologyhorizons.com.
